Have you heard about relatively new diabetes medications for weight loss? Mounjaro® is an injectable prescription medicine that is used to treat adults with type 2 diabetes mellitus. TIRZEPATIDE is the active ingredient in Mounjaro®. New weight loss injections are all medications that fall under the category of GLP-1 receptor agonists. This class of medications has been around since 2005.TIREPATIDE can help you can optimize your metabolism and boost weight loss. In clinical trials, weight loss in adults ranged from 12 - 25 pounds. Tirzepeptide is not yet FDA approved for the treatment of weight loss. Our clinic prescribes compounded version of TIRZEPATIDE and uses it "off label" for the treatment of weight loss.